Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brodalumab in Palmoplantar Psoriasis
NCT04622033Phase 4Unknown
- Sponsor
- First OC Dermatology
- Start
- Dec 2020
- Primary completion
- Nov 2021
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 4 trial of brodalumab in palmoplantar psoriasis, sponsored by First OC Dermatology. Status: unknown.
02
Drugs
brodalumab
03
Conditions
palmoplantar psoriasis
Beyond the preview
Go deeper on NCT04622033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04622033.